@article{4b3f642cd5b348f99dfb96271598d073,
title = "Just DOAC: Use of direct-acting oral anticoagulants in pediatrics",
keywords = "anticoagulants, pediatrics, thromboembolism, thrombosis, Administration, Oral, Humans, Dabigatran/adverse effects, Anticoagulants/adverse effects, Hemorrhage/chemically induced, Factor Xa Inhibitors/adverse effects, Venous Thromboembolism/drug therapy, Rivaroxaban/adverse effects, Child",
author = "Kimberly Mills and Carolyn Hill and Morgan King and Pauley, \{Jennifer L.\} and Cober, \{M. Petrea\} and Fenn, \{Norman E.\} and Omecene, \{Nicole E.\} and Tara Smith and Sierra, \{Caroline M.\}",
note = "Publisher Copyright: {\textcopyright} American Society of Health-System Pharmacists 2023.",
year = "2023",
month = apr,
day = "1",
doi = "10.1093/ajhp/zxac387",
language = "English",
volume = "80",
pages = "412--422",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
number = "7",
}